1,937 results on '"David Yaacov"'
Search Results
2. FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression
3. Rocaglamide reprograms glucose metabolism in erythroleukemic cells via c-MYC transcriptional regulation of TXNIP and HK2
4. Targeting pivotal amino acids metabolism for treatment of leukemia
5. A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K/AKT/FOXO3a axis and TNF signaling pathway
6. Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer
7. CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
8. Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling
9. A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer
10. Stilbene B10 induces apoptosis and tumor suppression in lymphoid Raji cells by BTK-mediated regulation of the KRAS/HDAC1/EP300/PEBP1 axis
11. FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes
12. A racemosin B derivative, C25, suppresses breast cancer growth via lysosomal membrane permeabilization and inhibition of autophagic flux
13. The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity.
14. FLI1 regulates inflammation-associated genes to accelerate leukemogenesis
15. UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression
16. An Overview of Heavy Metal Toxicity
17. Ubash3b promotes TPA-mediated suppression of leukemogenesis through accelerated downregulation of PKCδ protein
18. Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues
19. Light-Activated Nanoparticles for Antibacterial Studies
20. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation
21. The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease
22. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway
23. An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells
24. Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
25. ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes
26. BW18, a C-21 steroidal glycoside, exerts an excellent anti-leukemia activity through inducing S phase cell cycle arrest and apoptosis via MAPK pathway in K562 cells
27. B4 suppresses lymphoma progression by inhibiting fibroblast growth factor binding protein 1 through intrinsic apoptosis.
28. Synthesis of novel guttiferone E and xanthochymol derivatives with cytotoxicities by inducing cell apoptosis and arresting the cell cycle phase
29. Thinking (Metastasis) outside the (Primary Tumor) Box
30. Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer
31. Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
32. Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity
33. Erythropoietin
34. A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3
35. Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy
36. Gut microbiota and brain development: A review
37. Synthesis of Metal Nanoparticles from Fungi: A Biosynthesis Approach
38. Delivery of Peptides, Peptones and Proteins for Specific Intracellular Trafficking through Targeted Nanoparticles: Nanoparticle-assisted Cancer Drug Delivery Regimes
39. Light-Activated Nanoparticles for Antibacterial Studies
40. Erythropoietin
41. FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression
42. Molecular stratification within triple-negative breast cancer subtypes
43. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity
44. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis
45. Supplementary Figures 1 - 8, Tables 1 - 2 from mda-7/IL-24 Expression Inhibits Breast Cancer through Upregulation of Growth Arrest-Specific Gene 3 (gas3) and Disruption of β1 Integrin Function
46. Supplementary Figure S1 from Low-dose Metronomic Combined with Intermittent Bolus-dose Cyclophosphamide Is an Effective Long-term Chemotherapy Treatment Strategy
47. Data from Low-dose Metronomic Combined with Intermittent Bolus-dose Cyclophosphamide Is an Effective Long-term Chemotherapy Treatment Strategy
48. Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A
49. Syntheses and anti-cancer activities of glycosylated derivatives of diosgenin
50. The Effect of Pelvic Floor Rehabilitation on Males with Sexual Dysfunction: A Narrative Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.